Status:

RECRUITING

Prevalence of Cognitive Disorders in Newly Diagnosed Epilepsy

Lead Sponsor:

Central Hospital, Nancy, France

Conditions:

Epilepsy

Cognition

Eligibility:

All Genders

16+ years

Brief Summary

A prospective prevalence study recorded that up to 50% of adult patients with newly diagnosed epilepsy had at least one cognitive impairment before initiation of antiepileptic drug (AED). Multiple fac...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (patients):
  • Individuals who have received full information about the organization of the research and have not refused to participate and to use their data.
  • Person aged 16 and over
  • For minor patients: the non-opposition of the parental authority holders
  • Newly diagnosed epileptic patient who had never taken antiepileptic drugs.
  • Inclusion Criteria (normal controls):
  • Individuals who have received full information about the organization of the research and have not refused to participate and to use their data.
  • For minor participants: the non-opposition of the parental authority holders
  • Person aged 16 and over.
  • Exclusion Criteria (patients):
  • Person of full age who are subject to a legal protection measure or who are unable to express their consent
  • Person with a progressive brain injury
  • Person who regularly use psychoactive substances (cannabis, alcohol, etc.)
  • Patients who started an antiepileptic treatment before the neuropsychological assessment.
  • Exclusion Criteria (normal controls):
  • Persons of full age who are subject to a legal protection measure or who are unable to express their consent
  • Person with a neurological (traumatic brain injury, stroke, etc.) and/or psychiatric (mental illness, depression, etc.) history.
  • People who regularly use psychoactive substances (cannabis, alcohol, etc.).

Exclusion

    Key Trial Info

    Start Date :

    February 17 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 1 2026

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT04727931

    Start Date

    February 17 2021

    End Date

    February 1 2026

    Last Update

    January 26 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Department of neurology - Hospital of Nancy

    Nancy, France, 54000